CN111771971A - Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof - Google Patents
Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof Download PDFInfo
- Publication number
- CN111771971A CN111771971A CN202010716402.7A CN202010716402A CN111771971A CN 111771971 A CN111771971 A CN 111771971A CN 202010716402 A CN202010716402 A CN 202010716402A CN 111771971 A CN111771971 A CN 111771971A
- Authority
- CN
- China
- Prior art keywords
- extract
- portions
- composition
- oil
- promoting digestion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 64
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 230000001737 promoting effect Effects 0.000 title claims abstract description 45
- 230000029087 digestion Effects 0.000 title claims abstract description 39
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 230000001105 regulatory effect Effects 0.000 title claims description 37
- 239000000284 extract Substances 0.000 claims abstract description 77
- 239000000843 powder Substances 0.000 claims abstract description 59
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241000894006 Bacteria Species 0.000 claims abstract description 39
- 235000013305 food Nutrition 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 26
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 22
- 239000011707 mineral Substances 0.000 claims abstract description 22
- 235000013365 dairy product Nutrition 0.000 claims abstract description 20
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 20
- 239000004310 lactic acid Substances 0.000 claims abstract description 20
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 18
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 18
- 241000612118 Samolus valerandi Species 0.000 claims abstract description 18
- 235000020224 almond Nutrition 0.000 claims abstract description 18
- 235000019693 cherries Nutrition 0.000 claims abstract description 18
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- 239000008158 vegetable oil Substances 0.000 claims abstract description 17
- 235000020717 hawthorn extract Nutrition 0.000 claims abstract description 15
- 235000021323 fish oil Nutrition 0.000 claims abstract description 14
- 235000013339 cereals Nutrition 0.000 claims abstract description 8
- 235000013361 beverage Nutrition 0.000 claims abstract description 6
- 241000167854 Bourreria succulenta Species 0.000 claims abstract 4
- 241000218236 Cannabis Species 0.000 claims description 26
- 235000019197 fats Nutrition 0.000 claims description 21
- 235000010755 mineral Nutrition 0.000 claims description 21
- 108010046377 Whey Proteins Proteins 0.000 claims description 18
- 102000007544 Whey Proteins Human genes 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 12
- 238000004806 packaging method and process Methods 0.000 claims description 12
- 235000020183 skimmed milk Nutrition 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000005862 Whey Substances 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 238000001694 spray drying Methods 0.000 claims description 11
- 235000020238 sunflower seed Nutrition 0.000 claims description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 10
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 235000008939 whole milk Nutrition 0.000 claims description 9
- 229920001202 Inulin Polymers 0.000 claims description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 8
- 229940029339 inulin Drugs 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 235000020186 condensed milk Nutrition 0.000 claims description 7
- 235000005687 corn oil Nutrition 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- 239000003549 soybean oil Substances 0.000 claims description 7
- 235000012424 soybean oil Nutrition 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 235000021119 whey protein Nutrition 0.000 claims description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000002285 corn oil Substances 0.000 claims description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 6
- 235000021388 linseed oil Nutrition 0.000 claims description 6
- 239000000944 linseed oil Substances 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 6
- 239000011573 trace mineral Substances 0.000 claims description 6
- 235000013619 trace mineral Nutrition 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 4
- 229920001100 Polydextrose Polymers 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 239000001259 polydextrose Substances 0.000 claims description 4
- 235000013856 polydextrose Nutrition 0.000 claims description 4
- 229940035035 polydextrose Drugs 0.000 claims description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
- 235000008476 powdered milk Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000012946 outsourcing Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 238000007599 discharging Methods 0.000 claims 1
- 230000001502 supplementing effect Effects 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 30
- 230000036541 health Effects 0.000 abstract description 7
- 240000004308 marijuana Species 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 29
- 230000003405 preventing effect Effects 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 230000001603 reducing effect Effects 0.000 description 19
- 230000000968 intestinal effect Effects 0.000 description 18
- 241001290151 Prunus avium subsp. avium Species 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 13
- 235000013336 milk Nutrition 0.000 description 13
- 210000004080 milk Anatomy 0.000 description 13
- 239000008267 milk Substances 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 241000186000 Bifidobacterium Species 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- 235000016709 nutrition Nutrition 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 244000052616 bacterial pathogen Species 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000004626 essential fatty acids Nutrition 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 6
- 235000020778 linoleic acid Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 235000004426 flaxseed Nutrition 0.000 description 5
- 208000019622 heart disease Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- -1 sucrose triose group oligosaccharides Chemical class 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 244000018633 Prunus armeniaca Species 0.000 description 4
- 235000009827 Prunus armeniaca Nutrition 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010062877 Bacteriocins Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 241000208202 Linaceae Species 0.000 description 3
- 240000006240 Linum usitatissimum Species 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 239000003613 bile acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007580 dry-mixing Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241001092040 Crataegus Species 0.000 description 2
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 2
- 241000657480 Crataegus pinnatifida Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 2
- 235000020251 goat milk Nutrition 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 208000001297 phlebitis Diseases 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000015577 Armeniaca sibirica Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033649 Pancreatitis chronic Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 235000008104 Prunus humilis Nutrition 0.000 description 1
- 241000057271 Prunus humilis Species 0.000 description 1
- 235000013999 Prunus japonica Nutrition 0.000 description 1
- 241000392950 Prunus japonica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010058339 Splenitis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000002368 bacteriocinic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229940118852 bifidobacterium animalis Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000009326 ileitis Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940068140 lactobacillus bifidus Drugs 0.000 description 1
- 108010042648 lactocin Proteins 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004693 neuron damage Effects 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/005—Condensed milk; Sugared condensed milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a composition beneficial to adjusting intestinal tracts, promoting digestion and improving constipation and a preparation method thereof, relates to the technical field of foods, and can effectively maintain the health of human bodies and intestinal tracts. The composition beneficial to adjusting intestinal tracts, promoting digestion and improving constipation comprises the following components: 850 portions of dairy products 450 plus materials, 10-70 portions of refined vegetable oil, 40-200 portions of dietary fiber, 0.1-2 portions of fish oil powder, 5-30 portions of fructus cannabis extract, 5-30 portions of bunge cherry seed extract, 0.1-2 portions of almond extract, 0.1-2 portions of hawthorn extract, 0.5-5 portions of lactic acid bacteria and 4-20 portions of vitamins and minerals. The invention is mainly applied to the preparation of dairy products, cereal foods, beverages, health-care foods or medical formula foods.
Description
Technical Field
The invention relates to the technical field of food, in particular to a composition beneficial to adjusting intestinal tracts, promoting digestion and improving constipation and a preparation method thereof.
Background
At present, with the change of dietary structure, the life rhythm is accelerated, and the prevalence rate of chronic constipation shows a rising trend under the influence of psychosocial factors.
Therefore, how to provide a composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and a preparation method thereof have become technical problems to be solved urgently by the technical personnel in the field.
Disclosure of Invention
The invention aims to provide a composition which is beneficial to regulating intestinal tracts, promoting digestion and improving constipation so as to effectively maintain the health of human bodies and the intestinal tracts.
In order to achieve the purpose, the invention adopts the following technical scheme:
a composition for regulating intestinal tract, promoting digestion and improving constipation comprises the following components: 850 portions of dairy products 450 plus materials, 10-70 portions of refined vegetable oil, 40-200 portions of dietary fiber, 0.1-2 portions of fish oil powder, 5-30 portions of fructus cannabis extract, 5-30 portions of bunge cherry seed extract, 0.1-2 portions of almond extract, 0.1-2 portions of hawthorn extract, 0.5-5 portions of lactic acid bacteria and 4-20 portions of vitamins and minerals.
Specifically, the dairy product comprises: whole milk powder, skimmed milk powder, whey protein powder, desalted whey powder, and condensed milk.
Specifically, the refined vegetable oil comprises: soybean oil, linseed oil, sunflower seed oil, rapeseed oil, coconut oil and corn oil.
In particular, the dietary fiber comprises: inulin, fructo-oligosaccharide, polydextrose, resistant dextrin, galacto-oligosaccharide, stachyose, xylo-oligosaccharide, and isomerized lactose.
Specifically, the lactic acid bacteria include: any one or more of streptococcus thermophilus, lactobacillus delbrueckii subsp bulgaricus, lactobacillus acidophilus and bifidobacterium lactis.
Specifically, the vitamins and minerals include: water-soluble vitamins and trace elements; and/or, fat soluble vitamins and trace elements.
In practical application, the composition is applied to preparation of dairy products, cereal foods, beverages, health-care foods or medical formula foods.
Compared with the prior art, the composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation has the following advantages:
in the composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation, the dairy product can supplement various amino acids necessary for human bodies, the refined vegetable oil can meet the requirements of the human bodies on essential fatty acids, the fish oil powder can regulate blood fat and reduce triglyceride to play roles in preventing heart diseases and preventing and treating hypertension, the fructus cannabis extract can relax bowels to relieve blood deficiency and body fluid deficiency and constipation due to intestinal dryness, the bunge cherry seed extract can relax bowels to relieve constipation due to body fluid deficiency and intestinal dryness, food stagnation and qi stagnation and abdominal distension and constipation, the almond extract can lower qi to relieve cough and asthma, and relax bowels to relieve cough and asthma, chest fullness and phlegm and constipation due to intestinal dryness, and the hawthorn extract can improve and relieve intestinal tracts and constipation; in addition, the composition selects dairy products as main materials, other plant materials (fructus cannabis extract, bunge cherry seed extract, almond extract and hawthorn extract) which are homologous in medicine and food, dietary fibers and lactic acid bacteria as auxiliary materials, and vitamins and mineral substances are combined, so that the composition can be well combined with functionality and nutrition, and can be used for effectively regulating intestinal tracts, promoting digestion, improving constipation and further effectively maintaining human bodies and intestinal tract health.
A preparation method of a composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation comprises the following steps: cleaning fructus Cannabis, semen Pruni, semen Armeniacae amarum, and fructus crataegi respectively, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, and packaging to obtain fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract, and fructus crataegi extract;
the prepared fructus cannabis extract, bunge cherry seed extract, almond extract and hawthorn extract are mixed with dairy products, refined vegetable oil, dietary fiber, fish oil powder, lactic acid bacteria, vitamins and mineral substances to prepare the composition through the processes of bag removal sterilization, dosing, premixing, mixing and packaging.
Specifically, the fructus cannabis, the bunge cherry seed, the almond and the hawthorn are added with water according to the ratio of 1: 8-1: 15 respectively, the mixture is heated to be slightly boiled and is kept to be slightly boiled for 2-3 hours, the mixture is filtered, the filtrate is concentrated to the density of 1.06-1.12, the concentrated solution is taken to measure the content of solid matters, maltodextrin is added according to the proportion of medicinal materials to complement the weight and is uniformly stirred, after the maltodextrin is completely dissolved, and after spray drying, powder receiving, packaging and metal detection are carried out in a clean area of hundred thousand levels to prepare the extract.
Specifically, removing the outer package in a precise clean area, wiping the inner package with alcohol, performing ultraviolet sterilization through a tunnel, entering the clean area, performing precise proportioning, premixing a small part of material for 30min, mixing with a large part of material, performing powder feeding and filling after mixing for 20min, and performing precise calculation and metal detection treatment in the filling process;
wherein, the metal detection: respectively detecting and removing iron with the particle size not less than 0.7mm, nonferrous metal with the particle size not less than 1.0mm and stainless steel foreign matters with the particle size not less than 1.5 mm;
filling requirements are as follows: after the can is sealed, the vacuum pressure is detected to be between 7KPa and 15KPa, and the residual oxygen content is not more than 3 percent.
The preparation method of the composition beneficial to adjusting the intestinal tract, promoting digestion and improving constipation has the same advantages as the composition beneficial to adjusting the intestinal tract, promoting digestion and improving constipation compared with the prior art, and the detailed description is omitted.
Drawings
Fig. 1 is a schematic flow chart of a preparation method of a composition for regulating intestinal tract, promoting digestion and improving constipation, which is provided by the embodiment of the invention.
Detailed Description
For the convenience of understanding, the composition for regulating intestinal tract, promoting digestion and improving constipation and the preparation method thereof provided by the embodiments of the present invention are described in detail below with reference to the accompanying drawings.
The embodiment of the invention provides a composition beneficial to adjusting intestinal tracts, promoting digestion and improving constipation, which comprises the following components: 850 portions of dairy products 450 plus materials, 10-70 portions of refined vegetable oil, 40-200 portions of dietary fiber, 0.1-2 portions of fish oil powder, 5-30 portions of fructus cannabis extract, 5-30 portions of bunge cherry seed extract, 0.1-2 portions of almond extract, 0.1-2 portions of hawthorn extract, 0.5-5 portions of lactic acid bacteria and 4-20 portions of vitamins and minerals.
Compared with the prior art, the composition beneficial to regulating the intestinal tract, promoting digestion and improving constipation has the following advantages:
in the composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation, the dairy product can supplement various amino acids necessary for human bodies, the refined vegetable oil can meet the requirements of the human bodies on essential fatty acids, the fish oil powder can regulate blood fat and reduce triglyceride to play roles in preventing heart diseases and preventing and treating hypertension, the fructus cannabis extract can relax bowels to relieve blood deficiency and body fluid deficiency and constipation due to intestinal dryness, the bunge cherry seed extract can relax bowels to relieve constipation due to intestinal stasis and qi and promote diuresis to relieve body fluid dryness and intestinal dryness, food stagnation and qi stagnation and abdominal distension constipation, the almond extract can lower qi to relieve cough and asthma and relax bowel to relieve cough and asthma, chest fullness and excessive phlegm and constipation, and the hawthorn extract can improve and relieve intestinal tracts and constipation; in addition, the composition selects dairy products as main materials, other plant materials (fructus cannabis extract, bunge cherry seed extract, almond extract and hawthorn extract) which are homologous in medicine and food, dietary fibers and lactic acid bacteria as auxiliary materials, and vitamins and mineral substances are combined, so that the composition can be well combined with functionality and nutrition, and can be used for effectively regulating intestinal tracts, promoting digestion, improving constipation and further effectively maintaining human bodies and intestinal tract health.
In particular, the sources of the dairy product may include: whole milk powder, skimmed milk powder, whey protein powder, desalted whey powder, and condensed milk.
Further, the whole milk powder is a powdery product prepared by only taking cow milk or goat milk as a raw material through concentration and drying; the milk produced by pure milk basically keeps the original nutrient components in the milk, the protein is not less than 24 percent, the fat is not less than 26 percent, and the lactose is not less than 37 percent. The whole milk powder contains 25.5% of protein, 26.5% of fat and 37.3% of carbohydrate, and each hundred grams of the whole milk powder contains 979 mg of calcium, 685 mg of phosphorus, 1.9 mg of iron, 0.8 mg of riboflavin and 0.6 mg of nicotinic acid.
Furthermore, the skim milk powder is prepared by firstly removing fat in the cow milk through a high-speed centrifuge, and then concentrating and spray drying; it is common to produce 1 kg of skim milk powder with 12 kg of normal milk. The product generally has a fat content of no more than 2.0% and a protein content of no less than 32%. The skim milk powder is prepared by removing fat from fresh milk and drying, and the fat can be reduced to about 1 percent, and the other changes are not large; it is beneficial for the elderly, infants with dyspepsia, menstrual diarrhea, gallbladder diseases, hyperlipidemia, and chronic pancreatitis. In addition, the fat content of the skim milk powder is low, so the skim milk powder is easy to store and is not easy to generate oxidation; in addition, the skim milk powder does not contain fat, and is suitable for people who are obese and need to be supplemented with nutrition.
Further, whey protein powder is a precious protein separated and extracted from milk by an advanced process, and is called "king of protein" due to its advantages of high purity, high absorption rate, most reasonable amino acid composition, and the like. The whey protein is easy to digest, has high biological value, high efficiency, high protein efficiency ratio and high utilization rate, and is a fine product in the protein; contains all essential amino acids required by human body, and its amino acid composition pattern is almost identical to that of skeletal muscle, so that it can be easily absorbed by human body.
Further, the whey protein powder has the following effects: providing amino acids required by new tissues of the body structure, and delaying the aging of the human body; enzyme is produced in vivo, and gastrointestinal function is improved; making antibodies to the immune system against bacteria and infections; regulating the balance of water and electrolyte in the body, and enhancing the anti-fatigue capability of the body; oxygen and various nutrients are delivered to cells, and the body repair is accelerated. Is suitable for body building, hobbyists, athletes, people needing skin care, people with emaciation, people with fatigue, pregnant women, lactating mothers, children in growth and development period, operative rehabilitation people, anemia, hypertension and other chronic patients, and vegetarians.
Further, desalted whey powder refers to a whey product from which dissolved minerals and water are removed; the main components of the whey powder are whey protein and lactose; the desalted whey powder is prepared by removing mineral salts from whey powder. For infants, high mineral content increases the kidney burden of the baby, and therefore, the baby must be demineralized; in addition, the protein ratio can be adjusted to approach the level of breast milk.
Furthermore, condensed milk is a milk product, is a beverage prepared by sterilizing and concentrating fresh milk or goat milk, and is characterized by being capable of being stored for a long time; the milk is usually prepared by vacuum concentrating or other methods to remove most of water, concentrating to about 25-40% of original volume of milk product, adding 40% of sucrose, and canning. Refined milk contains more carbohydrates and ascorbic acid (vitamin C) than milk powder, and contains less other components such as protein, fat, minerals, vitamin A, etc.
Specifically, the sources of the refined vegetable oil described above may include: soybean oil, linseed oil, sunflower seed oil, rapeseed oil, coconut oil and corn oil.
Further, the soybean oil is an oil extracted by pressing from soybeans; the soybean oil contains a large amount of linoleic acid which is essential fatty acid for human body and has important physiological function. Moreover, soybean oil is sweet and pungent in flavor, hot in nature and slightly toxic; has effects in expelling intestinal parasites and moistening intestine; can be used for treating intestinal obstruction and constipation.
Further, linseed oil is prepared from flaxseed, which is the seed of flax, belonging to the family of linaceae, and is called flax, among others. The sum of the contents of crude protein, fat and total sugar in the flaxseed reaches 84.07%; the linseed protein has complete amino acid types, and the essential amino acid content is as high as 5.16 percent, so the linseed protein is a plant protein with higher nutritional value. The content of alpha-linolenic acid in the linseed oil is 53 percent, the alpha-linolenic acid is essential fatty acid for human body, can be converted into eicosapentaenoic acid and docosahexaenoic acid in human body, and is an effective active ingredient in the fish oil; the alpha-linolenic acid has the functions of resisting tumor, resisting thrombus, reducing blood fat, nourishing brain cells, regulating vegetative nerves and the like, and is concerned more; the linseed contains a large amount of polysaccharide, and the polysaccharide has the effects of resisting tumor, virus, thrombus and blood fat.
Further, linseed oil has the following functions: the skin is tender and bright, the fat content of the skin is improved, the skin is more tender, moist, soft and elastic, the skin can breathe and sweat normally, and various skin problems are reduced; can consume excessive fat of human body, and is a healthy weight-reducing food material; improving premenstrual syndrome of women, such as dysmenorrhea and the like; improving anti-stress, stabilizing mood, keeping calm, and reducing melancholia and insomnia; helps to alleviate allergic reactions; alleviating asthma attacks; has great effect on treating and preventing arthritis; can be used for preventing inflammation of organ and tissue, such as meningitis, tendinitis, tonsillitis, gastritis, ileitis, colitis, arteritis, phlebitis, prostate gland inflammation, nephritis, splenitis, hepatitis, pancreatitis, otitis, tinea and sore; can reduce high cholesterol content in blood by 25% and triglyceride 65%, convert excessive low density cholesterol (LDL) into cholic acid, and discharge; can reduce hypertension, reduce blood lipid content, increase unsaturated fatty acid level, improve blood concentration, reduce blood viscosity, maintain blood fluidity, and prevent blood vessel obstruction and related diseases; in addition, it can prevent blood coagulation, and prevent stroke (heart and cerebral artery blockage), heart disease (heart artery blockage), pulmonary artery embolism (pulmonary artery blockage) and blood vessel surface diseases (jaundice); help the kidney to remove sodium and water and improve water retention; improving renal function, regulating Prostaglandin (Prostaglandin), promoting liver, pancreas and spleen secretion, and normalizing metabolism; improving intestinal function, increasing absorption capacity, increasing intestinal peristalsis capacity to make defecation normal, and reducing constipation; improving water content and elasticity of cell membrane, increasing cell respiration and nutrition exchange function, enhancing repairing and healing capability of body cell, promoting cell health, and reducing cancer probability; the brain transmission medium (neuron) is added, the brain activity function is enhanced, the brain operation is more effective, and the learning and thinking ability is better; the blood sugar of the body is balanced and improved, so that people are more active, the endurance of muscles can be increased, and fatigue muscles after exercise can be recovered more quickly.
Furthermore, the sunflower seed oil contains a large amount of unsaturated fatty acids such as linoleic acid which are necessary for human bodies, can promote the regeneration and growth of human cells, protect the health of skin, and can reduce the accumulation of cholesterol in blood, thus being a high-grade nutritional oil. The sunflower seed oil contains various substances beneficial to human beings such as sterol, vitamin, linoleic acid and the like, wherein the content of natural vitamin E is the highest in all main vegetable oil; the content of linoleic acid can reach about 70%; the oleum Helianthi has effects of reducing serum cholesterol level, reducing triglyceride level, and lowering blood pressure. The sunflower seed oil is 90% unsaturated fatty acid, wherein linoleic acid accounts for about 66%, and also contains vitamin E, phytosterol, phospholipid, carotene and other nutritional ingredients. The sunflower seed oil also contains more vitamin E, and each hundred grams of the sunflower seed oil contains about 100 mg and 120 mg; has good functions of delaying human body cell aging and keeping youth; if the health-care food is eaten frequently, the health-care food can play a role in building up the body and prolonging the life. The sunflower seed oil also contains more vitamin B3, and has obvious curative effect on treating neurasthenia, depression and other mental diseases; the oral liquid contains a certain amount of protein and inorganic substances such as potassium, phosphorus, iron, magnesium and the like, is effective in treating diabetes and iron-deficiency anemia, and has important significance in promoting the healthy growth of bones and teeth of teenagers; it contains linoleic acid, which is essential fatty acid for human body, is helpful for human development and physiological regulation, and has positive effects in preventing xerosis cutis and scale hypertrophy. The linoleic acid contained in the sunflower seed oil is an essential fatty acid for human body, and it constitutes a basic component of various cells, and has the functions of regulating metabolism, maintaining blood pressure balance, and reducing cholesterol in blood. Sunflower seed oil contains trace amounts of phytol and phospholipids, which prevent the increase of serum cholesterol. Sunflower oil contains abundant carotene, and the content of the carotene is more than that of peanut oil, sesame oil and soybean oil; therefore, it can reduce serum cholesterol concentration, prevent arteriosclerosis and vascular diseases, and is suitable for hypertension patients and middle-aged and elderly people.
Furthermore, the rapeseed oil has certain efficacies of softening blood vessels and delaying senility; the absorption rate of the rapeseed oil by human body is very high and can reach 99%.
Further, the coconut oil is endosperm of coconut of palm plant, and is squeezed oil after being crushed, dried and steamed; the oil contains 20% of free fatty acid, 2% of linoleic acid, 7% of palmitic acid, 9% of caprylic acid, 5% of cerotic acid, 10% of capric acid, 2% of oleic acid and 45% of lauric acid; the sterol of coconut oil contains stigmasterol trienol 4.5%, stigmasterol and fucosterol 31.5%, alpha-spinasterol and sterol 6%, and beta-sitosterol 58%.
Further, corn oil, also called maize oil, maize germ oil, is an oil extracted from maize germ; the fat content of the maize germ is between 17 and 45 percent, and accounts for more than 80 percent of the total content of the maize fat; the fatty acid in the corn oil is characterized in that the content of unsaturated fatty acid is as high as 80-85%. The corn oil does not contain cholesterol, has a dissolving effect on the accumulation of cholesterol in blood, and can reduce the influence on the hardening of blood vessels; has positive effects in preventing and treating senile diseases such as arteriosclerosis and diabetes; owing to the function of natural vitamin E complex, the medicine has obvious curative effect and preventing effect on heart disease, thrombotic phlebitis, reproductive function disorder, amyotrophic lateral sclerosis and nutritional encephalic softening disease.
Specifically, the sources of the dietary fiber may include: inulin, fructo-oligosaccharide, polydextrose, resistant dextrin, galacto-oligosaccharide, stachyose, xylo-oligosaccharide, and isomerized lactose.
Further, inulin is a reserve polysaccharide in plants, mainly derived from plants, which has the following effects: controlling blood fat; reducing blood sugar; promoting the absorption of minerals; regulating intestinal microbial flora, improving intestinal health, and preventing constipation; inhibiting the generation of toxic fermentation product, protecting liver, and preventing colon cancer. In addition, the dietary fiber for preventing constipation and treating obesity reduces the retention time of food in the stomach and intestine, and increases the quantity of excrement, thereby effectively treating constipation; the weight reducing effect is to increase the viscosity of the contents and reduce the speed of food entering the small intestine from the stomach, thereby reducing hunger sensation and food intake. The inulin contains a small amount of 2-9 fructo-oligosaccharide, which can increase the expression of brain nerve cell trophic factor, and has good protection effect on corticosterone induced neuron damage and good antidepressant effect.
Furthermore, fructooligosaccharides are also called oligofructose or sucrose triose group oligosaccharides; fructooligosaccharides are found in many fruits and vegetables that are commonly consumed. Fructo-oligosaccharide is one of the most widely applied prebiotics, and has been proved to be the only all-natural ingredient with the dual physiological characteristics of super-strong bifidus factors and water-soluble dietary fibers.
Furthermore, polydextrose is a water-soluble dietary fiber and has a special physiological metabolic function after entering the digestive system of a human body, so that constipation and fat deposition can be prevented and treated. It has the following effects; regulating lipid metabolism, forming a film in small intestine, wrapping part of food fat, effectively limiting fat absorption in digestive tract, promoting lipid excretion, increasing satiety, and reducing food intake, thereby regulating blood lipid, reducing fat accumulation, and preventing obesity; reducing cholesterol, adsorbing organic molecules such as bile acid and cholesterol mutagen, inhibiting Total Cholesterol (TC) concentration increase, reducing synthesis and absorption of cholic acid and salts, reducing cholesterol level in human blood plasma and liver, preventing and treating coronary arteriosclerosis and cholelithiasis, and preventing cardiovascular and cerebrovascular diseases; reducing sugar absorption, preventing food from contacting with digestive juice, inhibiting secretion of hyperglycosemin, and slowing glucose absorption, so as to reduce postprandial blood sugar level, give full play to insulin effect, and prevent diabetes; preventing and treating constipation, absorbing water and swelling in intestinal tract of human body, keeping water, increasing feces volume, stimulating intestinal tract peristalsis, accelerating defecation frequency, and relieving constipation and preventing constipation; the composition can expel toxin and beautify the face, can effectively adjust the pH value of an intestinal tract, improve the breeding environment of beneficial bacteria, and rapidly expand beneficial bacteria such as bifidobacterium and the like, thereby inhibiting the growth of saprophytic bacteria, preventing the atrophy of the intestinal tract mucous membrane, timely excreting in-vivo toxin and metabolic waste, avoiding toxin from being discharged from the skin, achieving the effects of beautifying the skin and beautifying the face, and preventing diseases such as hemorrhoids, gastroenteritis, colon cancer and the like.
Furthermore, the resistant dextrin is processed by starch, is a low-calorie glucan which is obtained by extracting and refining indigestible components of the baked dextrin by using industrial technology, and belongs to low-molecular water-soluble dietary fiber.
Furthermore, stachyose is a naturally occurring tetrasaccharide, and is a functional oligosaccharide which can significantly promote the proliferation of beneficial bacteria such as bifidobacterium and the like. Stachyose has obvious proliferation effect on beneficial bacteria such as bifidobacterium, lactobacillus and the like in the gastrointestinal tract of a human body, can quickly improve the environment in the digestive tract of the human body and adjust the balance of microecological bacteria; it can promote the formation of dominant bacteria status of beneficial bacteria in digestive tract, inhibit the production of putrefying bacteria such as Clostridium acidogenum and the like, produce a large amount of physiological active substances, regulate the pH value of intestinal tract, kill pathogenic bacteria, inhibit the generation of putrefying products, inhibit the generation and absorption of endogenous carcinogens, and decompose and derive multiple immune function factors. In addition, stachyose can effectively prevent and relieve constipation and diarrhea of infants and inhibit intestinal diseases; the immunity of the infants can be comprehensively enhanced, and the body disease resistance of the infants is improved; has effects in clearing intestinal tract, removing toxic substances, and removing lead; can replace metal ions, thereby promoting the absorption of minerals such as calcium.
Further, xylo-oligosaccharide has the following effects: the production of toxic fermentation products and harmful bacterial enzymes is reduced; pathogenic bacteria and diarrhea are inhibited, and the adsorption capacity to the pathogenic bacteria is strong, such as escherichia coli, enteritis phylum bacteria, Klebsiella pneumoniae, aeromonas hydrophila and the like can be adsorbed onto xylo-oligosaccharide, and the xylo-oligosaccharide is not degraded by digestive enzymes in the intestinal tract and can carry the attached pathogenic bacteria to be discharged out of the body through the intestinal tract, so that the diseases are prevented from being clustered in the intestinal tract, and the purpose of preventing the diarrhea is achieved; the bifidobacterium uses xylo-oligosaccharide to produce a large amount of short-chain fatty acid, so that intestinal tract movement can be stimulated, the stool wetness is increased, and a certain osmotic pressure is kept, thereby preventing constipation; the liver function is protected, the formation of toxic metabolites can be reduced, and the burden of decomposing toxins by the liver is greatly reduced; reducing serum cholesterol, and increasing the ratio of total cholesterol in female serum; lowering blood pressure; the bifidobacterium can enhance the immunity of the organism and resist cancer, and the bifidobacterium can play a role in resisting cancer by propagating in large quantities in the intestinal tract, and the anticancer effect is attributed to the cells, cell wall components and extracellular secretion of the bifidobacterium, so that the immunity of the organism is improved; the calcium absorption enhancer has good compatibility, does not influence the absorption of calcium by organisms, and can play a role in promoting; can promote organism to generate various nutrients including vitamin B1, B2, B6, B12, nicotinic acid and folic acid; preventing and protecting dental caries, and inhibiting growth of oral bacteria.
Further, the isomerized lactose is a prebiotic, has the functions of proliferating bifidobacteria, improving the intestinal environment and improving the intestinal health, and is a laxative. It can promote absorption of calcium and magnesium ions; has an excellent effect of inhibiting putrefying bacteria; has blood sugar lowering effect, and can be eaten by diabetic patients.
Specifically, the sources of the above lactic acid bacteria may include: any one or more of streptococcus thermophilus, lactobacillus delbrueckii subsp bulgaricus, lactobacillus acidophilus and bifidobacterium lactis.
Further, streptococcus thermophilus has the following effects: improving intestinal microenvironment, reducing intestinal pH value, promoting intestinal peristalsis, preventing pathogenic bacteria colonization, and secreting bacteriocin to inhibit pathogenic bacteria growth; regulating blood pressure, inhibiting cholesterol synthetase activity, and reducing cholesterol content in blood serum, wherein the fermented product can regulate and control blood pressure; the produced polysaccharide, bacteriocin, lactic acid and the like have the effect of resisting tumor activity, and can resist the generation of tumors by activating the immune system of an organism and inhibiting the mutation of cells; delaying aging, and generating superoxide dismutase (SOD) which can eliminate excessive superoxide anion free radical generated in vivo metabolism process, and delaying aging; lactic acid is produced, the degradation of lactose requires a special enzyme, called beta-galactosidase, which is deficient in the human body of lactose intolerance, streptococcus thermophilus is a bacterium that can produce beta-galactosidase, so that the digestion of lactose can be assisted; the survival rate of the streptococcus thermophilus in an acid solution with pH =6.8 is 100%, the survival rate of the streptococcus thermophilus in an acid solution with pH =4 is about 75%, the survival rate of the streptococcus thermophilus in an acid solution with pH =3 is about 70%, and the streptococcus thermophilus can live in bile with higher concentration, so the streptococcus thermophilus can be prevented from being damaged by the bile to reach the far end of a small intestine in vivo.
Furthermore, the lactic acid bacteria in the Bulgaria yoghurt belong to the lactobacilli in classification, and are named as Lactobacillus delbrueckii Bulgaria subspecies (abbreviated as Bulgaria lactobacilli) by microbiologists due to the characteristics of excellent strain producing area, microbial characteristics, efficiency and the like.
Further, lactobacillus acidophilus can regulate the balance of intestinal flora and inhibit the proliferation of intestinal undesirable microorganisms; lactobacillus acidophilus can secrete antibiotic substances (acidophilic lactocin (acidophilolin), acidophilic bacteriocin (acidophilophilin) and lactobacillin (1 aerocidin)), and has antagonistic effect on intestinal pathogenic bacteria. A leavening agent formed by mixing lactobacillus acidophilus (A) and lactobacillus bifidus (B); the intake of the milk food containing the two live bacteria is beneficial to digestive organs, and particularly has good nutrition and health care effects on infants with gastrointestinal dysfunction and patients with gastrointestinal dysfunction caused by long-term oral administration of antibiotics, and after the fermented milk containing the two live bacteria is eaten, the normal balance of flora in intestinal tracts can be rapidly restored, and the proliferation of putrefying bacteria is inhibited.
Further, bifidobacterium lactis is able to inhibit the growth of spoilage bacteria: when high concentration level animal bifidobacterium exists in the intestinal tract, the exogenous pathogenic escherichia coli, shigella dysenteriae, salmonella typhi, proteus, staphylococcus aureus, candida albicans or endogenous saprophytic bacteria and conditional pathogenic bacteria are inhibited. The antibacterial mechanism mainly comprises four aspects: the animal bifidobacterium can be rapidly planted on the intestinal mucosa to form a beneficial bacterium barrier and densely distributed on the intestinal mucosa to form a bacterial film, so that pathogenic bacteria cannot be planted; acetic acid and lactic acid generated by animal bifidobacterium reduce the pH value of the intestinal tract, thereby achieving the purpose of inhibiting saprophytic bacteria; produce bacteriocin-like protein and have certain bactericidal effect; bifidobacterium animalis can decompose coupled bile acid into free bile acid, which has strong bacteria inhibiting effect.
Specifically, sources of the above vitamins and minerals may include: water-soluble vitamins and trace elements; and/or, fat soluble vitamins and trace elements.
In practical application, the composition provided by the embodiment of the invention can be applied to the preparation of dairy products, cereal foods, beverages, health foods or medical formula foods.
The embodiment of the invention also provides a preparation method of the composition beneficial to regulating the intestinal tract, promoting digestion and improving constipation, and as shown in figure 1, the preparation method can comprise the following steps:
step S1, respectively washing fructus Cannabis, semen Pruni, semen Armeniacae amarum, and fructus crataegi, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, and packaging to obtain fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract, and fructus crataegi extract;
step S2, the prepared fructus cannabis extract, bunge cherry seed extract, almond extract, hawthorn extract, dairy products, refined vegetable oil, dietary fiber, fish oil powder, lactic acid bacteria, vitamins and mineral substances are subjected to bag removing and sterilization, dosing, premixing, mixing and packaging processes to prepare the composition.
Specifically, the step S1 may be: adding water into fructus cannabis, bunge cherry seed, almond and hawthorn respectively according to the proportion of 1: 8-1: 15, heating until the mixture is slightly boiled, keeping the slightly boiling for 2-3 hours, filtering, concentrating the filtrate until the density is 1.06-1.12, taking the concentrated solution to measure the content of solid matters, adding maltodextrin according to the proportion of medicinal materials to complement the weight, uniformly stirring, after the maltodextrin is completely dissolved, carrying out spray drying, carrying out powder receiving, packaging and metal detection in a hundred thousand grade clean area to prepare the extract.
Specifically, the step S2 may be: the outsourcing is taken off in accurate clean district, and the inner packing is cleaned to alcohol, through tunnel ultraviolet sterilization back, gets into clean district, through accurate batching after, mixes little share material in advance after 30min, mixes with the volume of share material again, mixes 20min after, carries out the lower powder filling, carries out accurate calculation and metal detection processing among the filling process.
Wherein, the metal detection: respectively detecting and removing iron with the grain diameter not less than 0.7mm, nonferrous metal with the grain diameter not less than 1.0mm and stainless steel foreign matters with the grain diameter not less than 1.5 mm.
Wherein, the filling requirement is as follows: after the can is sealed, the vacuum pressure is detected to be between 7KPa and 15KPa, and the residual oxygen content is not more than 3 percent.
The first embodiment is as follows:
a composition helpful for regulating intestinal tract, promoting digestion and improving constipation is prepared from the following raw materials by a dry mixing process:
380 parts of whole milk powder, 250 parts of skim milk powder, 180 parts of desalted whey powder, 20 parts of refined vegetable oil, 70 parts of inulin, 20 parts of condensed milk powder, 30 parts of xylo-oligosaccharide, 15 parts of fructus cannabis extract, 15 parts of bunge cherry seed extract, 1 part of almond extract, 1.1 parts of hawthorn extract, 10 parts of isomer lactose, 1 part of fish oil powder, 0.9 part of lactic acid bacteria, 3 parts of compound vitamin and 3 parts of compound mineral substance.
Mixing all above materials uniformly to obtain composition for regulating intestinal tract, promoting digestion and improving constipation, wherein fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract and fructus crataegi extract can be obtained by cleaning, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, packaging, etc.
Example two:
a composition helpful for regulating intestinal tract, promoting digestion and improving constipation is prepared from the following raw materials by a dry mixing process:
450 parts of whole milk powder, 290 parts of skim milk powder, 110 parts of desalted whey powder, 10 parts of refined vegetable oil, 50 parts of inulin, 10 parts of condensed milk powder, 40 parts of xylo-oligosaccharide, 9 parts of fructus cannabis extract, 5 parts of bunge cherry seed extract, 0.5 part of almond extract, 2 parts of hawthorn extract, 15 parts of isomer lactose, 2 parts of fish oil powder, 0.5 part of lactic acid bacteria, 3 parts of compound vitamin and 3 parts of compound mineral substance.
Mixing all above materials uniformly to obtain composition for regulating intestinal tract, promoting digestion and improving constipation, wherein fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract and fructus crataegi extract can be obtained by cleaning, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, packaging, etc.
Example three:
a composition helpful for regulating intestinal tract, promoting digestion and improving constipation is prepared from the following raw materials by a dry mixing process:
300 parts of whole milk powder, 230 parts of skim milk powder, 250 parts of desalted whey powder, 30 parts of refined vegetable oil, 90 parts of inulin, 30 parts of condensed milk powder, 35 parts of xylo-oligosaccharide, 5 parts of fructus cannabis extract, 11 parts of bunge cherry seed extract, 1.3 parts of almond extract, 1.5 parts of hawthorn extract, 5 parts of isomer lactose, 0.7 part of fish oil powder, 4.5 parts of lactic acid bacteria, 3 parts of compound vitamin and 3 parts of compound mineral substance.
Mixing all above materials uniformly to obtain composition for regulating intestinal tract, promoting digestion and improving constipation, wherein fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract and fructus crataegi extract can be obtained by cleaning, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, packaging, etc.
The composition beneficial to adjusting intestinal tracts, promoting digestion and improving constipation and the preparation method thereof provided by the embodiment of the invention mainly have the following advantages:
firstly, the selected protein is derived from milk protein, and various amino acids necessary for a human body are supplemented by complete protein;
secondly, the selected refined vegetable oil can meet the requirement of a human body on essential fatty acid;
thirdly, the selected fish oil powder is rich in DHA and EPA, can regulate blood fat and reduce triglyceride, and has the effects of preventing heart disease, preventing and treating hypertension and the like;
fourthly, the selected medicinal and edible extracts are prepared by the processes of cleaning, airing, crushing, water extracting, filtering, concentrating, spray drying, packaging and the like, and are safe and reliable;
fifthly, the selected fructus cannabis extract is an extract of dry mature fruits of cannabis sativa of Moraceae, has the effect of relaxing bowel, and can be used for improving blood deficiency and body fluid deficiency, and constipation due to intestinal dryness;
sixthly, the selected bunge cherry seed extract is an extract of dry mature seeds of prunus humilis, prunus japonica or longstalck peach of the Rosaceae family, has the functions of relaxing bowel, descending qi and inducing diuresis, and can be used for improving body fluid dryness, intestinal dryness, food retention, qi stagnation, abdominal distension and constipation;
seventhly, the selected almond extract is an extract of dry mature seeds of the Povidae family plants of the wild apricot, the Siberian apricot, the northeast apricot and the apricot white, has the functions of depressing qi, relieving cough and asthma and relaxing bowel, and can be used for improving cough and asthma, fullness in chest and excessive phlegm and constipation due to intestinal dryness;
eighthly, the selected hawthorn extract is an extract of dried mature fruits of Crataegus pinnatifida or Crataegus pinnatifida of Rosaceae, and can improve and relieve intestinal tract and constipation;
selecting dairy products as main materials, using other plant materials with homology of medicine and food, dietary fibers and lactic acid bacteria as auxiliary materials, and combining vitamins and mineral substances to effectively realize the combination of functionality and nutrition, wherein the composition belongs to the first example;
the composition can be applied to the preparation of dairy products, cereal foods, beverages, health-care foods and formula foods with special medical application.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (10)
1. A composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation is characterized by comprising the following components: 850 portions of dairy products 450 plus materials, 10-70 portions of refined vegetable oil, 40-200 portions of dietary fiber, 0.1-2 portions of fish oil powder, 5-30 portions of fructus cannabis extract, 5-30 portions of bunge cherry seed extract, 0.1-2 portions of almond extract, 0.1-2 portions of hawthorn extract, 0.5-5 portions of lactic acid bacteria and 4-20 portions of vitamins and minerals.
2. The composition for regulating intestinal tract, promoting digestion and improving constipation according to claim 1, wherein the dairy product comprises: whole milk powder, skimmed milk powder, whey protein powder, desalted whey powder, and condensed milk.
3. The composition for facilitating the regulation of intestinal tract, promoting digestion and improving constipation according to claim 1, wherein said refined vegetable oil comprises: soybean oil, linseed oil, sunflower seed oil, rapeseed oil, coconut oil and corn oil.
4. The composition for regulating intestinal tract, promoting digestion and improving constipation according to claim 1, wherein the dietary fiber comprises: inulin, fructo-oligosaccharide, polydextrose, resistant dextrin, galacto-oligosaccharide, stachyose, xylo-oligosaccharide, and isomerized lactose.
5. The composition for regulating intestinal tract, promoting digestion and improving constipation according to claim 1, wherein said lactic acid bacteria comprise: any one or more of streptococcus thermophilus, lactobacillus delbrueckii subsp bulgaricus, lactobacillus acidophilus and bifidobacterium lactis.
6. The composition for regulating the intestinal tract, promoting digestion and improving constipation according to claim 1, wherein said vitamins and minerals comprise: water-soluble vitamins and trace elements;
and/or, fat soluble vitamins and trace elements.
7. The composition for regulating intestinal tract, promoting digestion and improving constipation according to any one of claims 1 to 6, wherein the composition is applied to the preparation of dairy products, cereal foods, beverages, health foods or medical formula foods.
8. A preparation method of a composition beneficial to regulating intestinal tracts, promoting digestion and improving constipation is characterized by comprising the following steps:
cleaning fructus Cannabis, semen Pruni, semen Armeniacae amarum, and fructus crataegi respectively, air drying, pulverizing, extracting with water, filtering, concentrating, spray drying, and packaging to obtain fructus Cannabis extract, semen Pruni extract, semen Armeniacae amarum extract, and fructus crataegi extract;
the prepared fructus cannabis extract, bunge cherry seed extract, almond extract and hawthorn extract are mixed with dairy products, refined vegetable oil, dietary fiber, fish oil powder, lactic acid bacteria, vitamins and mineral substances to prepare the composition through the processes of bag removal sterilization, dosing, premixing, mixing and packaging.
9. The method for preparing a composition beneficial for regulating intestinal tracts, promoting digestion and improving constipation according to claim 8, wherein the extract is prepared by adding water to fructus cannabis, bunge cherry seed, almond and hawthorn in a ratio of 1: 8-1: 15, respectively, heating to slightly boil, keeping slightly boiling for 2-3 hours, filtering, concentrating the filtrate to a density of 1.06-1.12, measuring the solid content of the concentrated solution, adding maltodextrin in a proportion to the medicinal materials, supplementing the weight, uniformly stirring, completely dissolving the maltodextrin, spray-drying, and carrying out powder receiving, packaging and metal detection processes in a hundred thousand clean area.
10. The method for preparing a composition beneficial to intestinal tract regulation, digestion promotion and constipation improvement according to claim 8 or 9, characterized in that the quasi-clean area is subjected to outsourcing, the inner package is wiped by alcohol, the tunnel ultraviolet sterilization is performed, the tunnel ultraviolet sterilization enters the clean area, after precise batching is performed, a small part of the material is premixed for 30min, then the large part of the material is mixed, after 20min, powder discharging and filling are performed, and during filling, precise calculation and metal detection processing are performed;
wherein, the metal detection: respectively detecting and removing iron with the particle size not less than 0.7mm, nonferrous metal with the particle size not less than 1.0mm and stainless steel foreign matters with the particle size not less than 1.5 mm;
filling requirements are as follows: after the can is sealed, the vacuum pressure is detected to be between 7KPa and 15KPa, and the residual oxygen content is not more than 3 percent.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010716402.7A CN111771971A (en) | 2020-07-23 | 2020-07-23 | Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof |
PCT/CN2020/134191 WO2022016774A1 (en) | 2020-07-23 | 2020-12-07 | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010716402.7A CN111771971A (en) | 2020-07-23 | 2020-07-23 | Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111771971A true CN111771971A (en) | 2020-10-16 |
Family
ID=72763215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010716402.7A Pending CN111771971A (en) | 2020-07-23 | 2020-07-23 | Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111771971A (en) |
WO (1) | WO2022016774A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113475581A (en) * | 2021-06-30 | 2021-10-08 | 杨树强 | Food for cleaning intestinal garbage and preparation method and application thereof |
WO2022016774A1 (en) * | 2020-07-23 | 2022-01-27 | 江西人之初乳品营养有限公司 | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor |
CN114343180A (en) * | 2022-01-25 | 2022-04-15 | 山东安然纳米实业发展有限公司 | A series of compositions with effects of clearing hollow viscera and removing toxic substance, and its application |
CN115005431A (en) * | 2022-06-13 | 2022-09-06 | 江南大学 | Special diet for old people and application thereof |
CN115053929A (en) * | 2022-05-23 | 2022-09-16 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for people with fatty liver and preparation method thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114525233B (en) * | 2022-04-22 | 2022-07-22 | 中国疾病预防控制中心传染病预防控制所 | Application of lactobacillus sake and stachyose composition in preparation of medicine for treating constipation |
CN116832084B (en) * | 2023-07-31 | 2024-05-17 | 苏州市中医医院 | Composition for treating constipation and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102613287A (en) * | 2011-01-28 | 2012-08-01 | 张天平 | Dietary fiber lactobacillus beverage |
CN104223074A (en) * | 2014-09-17 | 2014-12-24 | 胡安然 | Total-nutrition formula food for preventing constipation |
CN107183705A (en) * | 2017-04-11 | 2017-09-22 | 凯泽(武汉)健康管理有限公司 | A kind of relax bowel improves the functional food of constipation |
CN107568341A (en) * | 2017-10-28 | 2018-01-12 | 卜球 | A kind of formula milk and its production method for being advantageous to human body intestinal canal health |
CN110338402A (en) * | 2018-04-08 | 2019-10-18 | 王康学 | A kind of compound probiotic powder and preparation method thereof |
CN110859219A (en) * | 2019-12-04 | 2020-03-06 | 深圳市百家赞食品科技有限公司 | Probiotic plant yoghurt powder |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241983B1 (en) * | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
CN105394760A (en) * | 2015-12-09 | 2016-03-16 | 郑州郑先医药科技有限公司 | Nutrition food agent for improving intestinal tract health and making method thereof |
CN110214948A (en) * | 2019-07-07 | 2019-09-10 | 广州正广生物科技有限公司 | A kind of composition and preparation method thereof with function of relaxing bowel |
CN111771971A (en) * | 2020-07-23 | 2020-10-16 | 江西人之初乳品营养有限公司 | Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof |
-
2020
- 2020-07-23 CN CN202010716402.7A patent/CN111771971A/en active Pending
- 2020-12-07 WO PCT/CN2020/134191 patent/WO2022016774A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102613287A (en) * | 2011-01-28 | 2012-08-01 | 张天平 | Dietary fiber lactobacillus beverage |
CN104223074A (en) * | 2014-09-17 | 2014-12-24 | 胡安然 | Total-nutrition formula food for preventing constipation |
CN107183705A (en) * | 2017-04-11 | 2017-09-22 | 凯泽(武汉)健康管理有限公司 | A kind of relax bowel improves the functional food of constipation |
CN107568341A (en) * | 2017-10-28 | 2018-01-12 | 卜球 | A kind of formula milk and its production method for being advantageous to human body intestinal canal health |
CN110338402A (en) * | 2018-04-08 | 2019-10-18 | 王康学 | A kind of compound probiotic powder and preparation method thereof |
CN110859219A (en) * | 2019-12-04 | 2020-03-06 | 深圳市百家赞食品科技有限公司 | Probiotic plant yoghurt powder |
Non-Patent Citations (3)
Title |
---|
杨建峰主编: "《本草纲目精华》", 28 February 2014, 江西科学技术出版社 * |
樊蔚虹编著: "《中药滋补与养生药膳速查百科:畅销升级版》", 31 July 2014, 浙江科学技术出版社 * |
胡维勤主编: "《多吃粗粮少生病》", 30 November 2016, 新疆人民卫生出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022016774A1 (en) * | 2020-07-23 | 2022-01-27 | 江西人之初乳品营养有限公司 | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor |
CN113475581A (en) * | 2021-06-30 | 2021-10-08 | 杨树强 | Food for cleaning intestinal garbage and preparation method and application thereof |
CN114343180A (en) * | 2022-01-25 | 2022-04-15 | 山东安然纳米实业发展有限公司 | A series of compositions with effects of clearing hollow viscera and removing toxic substance, and its application |
CN115053929A (en) * | 2022-05-23 | 2022-09-16 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for people with fatty liver and preparation method thereof |
CN115053929B (en) * | 2022-05-23 | 2024-04-23 | 江西人之初乳品营养有限公司 | Formula milk powder suitable for fatty liver people and preparation thereof |
CN115005431A (en) * | 2022-06-13 | 2022-09-06 | 江南大学 | Special diet for old people and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2022016774A1 (en) | 2022-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022016774A1 (en) | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor | |
CN106954847A (en) | Ferment probiotic composition with function of relaxing bowel, using and process preparation | |
CN105995976A (en) | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof | |
CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
CN109430407A (en) | Probiotic combinations preparation | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
CN105722514A (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN109846035A (en) | A kind of compound probiotic composition with body weight control | |
CN103110861A (en) | Granular preparation for preventing infants from getting inflamed and adjusting intestines and stomach and preparation method thereof | |
CN102742653B (en) | Brain-strengthening and nerve soothing probiotic goat milk tablet and preparation method of brain-strengthening and nerve soothing probiotic goat milk tablet | |
CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
CN111955720A (en) | Special postpartum lactation-promoting diet for puerpera and preparation method thereof | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN113974043A (en) | Prebiotics solid beverage and preparation method thereof | |
CN114711374A (en) | Composite nutrient powder of ferment fibre and its preparation method | |
CN105802876B (en) | A kind of composite probiotics ferment clover tender shoots powder preparation and its preparation method and application | |
KR20210067990A (en) | The composition for health of the intestine preparation method thereof | |
CN111248384A (en) | Composite probiotic enzyme beverage and preparation method thereof | |
KR102000170B1 (en) | Food compositions for reducing body fat and improving intestinal function | |
KR20040037011A (en) | Food Composition Containing a Lactic Acid Bacteria | |
CN102742654B (en) | Beautification probiotic ewe milk tablet and preparation method thereof | |
CN102754695A (en) | Burdock probiotics goat milk slices and method for preparing same | |
CN109043555A (en) | A kind of Special food and preparation method thereof that hyperglycemic patients are edible |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201016 |